Related Experiment Video
Updated: Feb 7, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Current status of G-protein coupled receptors as potential targets against type 2 diabetes mellitus
Mehboob Hoque1, Safdar Ali1, Muddasarul Hoda1
1Department of Biological Sciences, Aliah University, Kolkata 700 160, India.
Abstract:
GPCRs are among the most abundant surface receptors that play diverse roles including cell signalling and molecular transportation. They are major therapeutic receptor targets against various diseases like cancer and diabetes. A number of new GPCRs are being consistently being identified and deorphanised. Among them, some GPCRs are constitutively expressed while others are down-regulated. New therapeutic agents in the form of small molecule, synthetic peptides, and recombinant nucleic acids and proteins act as antagonists and agonists against various GPCR targets that potentially regulate glucose homeostasis. In the current review, we intend to summarize the various categories of GPCRs. At the same time, we intend to highlight the major GPCRs that have been targeted by various pharmaceutical companies against diabetes mellitus. In addition, we intended to summarize the most recently identified orphan GPCRs and their therapeutic potential against diabetes.
Insights
This review summarizes G protein-coupled receptors (GPCRs) and their therapeutic potential for diabetes. It highlights key GPCR targets and novel orphan GPCRs for glucose homeostasis regulation.
Area of Science:
- Biochemistry and Pharmacology
- Endocrinology
- Molecular Biology
Background:
- G protein-coupled receptors (GPCRs) are crucial cell surface receptors involved in signaling and transport.
- They represent significant therapeutic targets for diseases including cancer and diabetes mellitus.
- Ongoing research continually identifies and deorphanizes new GPCRs with varying expression patterns.
Purpose of the Study:
- To categorize the diverse classes of GPCRs.
- To identify major GPCR targets currently pursued for diabetes mellitus treatment.
- To review recently discovered orphan GPCRs and their potential in managing diabetes.
Main Methods:
- Literature review of GPCRs.
- Analysis of pharmaceutical industry targets for diabetes.
- Summary of orphan GPCR identification and functional studies.
Main Results:
- GPCRs are implicated in glucose homeostasis through various regulatory mechanisms.
- Several GPCRs are actively targeted by therapeutic agents (small molecules, peptides, nucleic acids, proteins) acting as agonists or antagonists.
- Newly identified orphan GPCRs show promise for future diabetes therapies.
Conclusions:
- GPCRs represent a vital class of therapeutic targets for diabetes mellitus.
- Targeting specific GPCRs offers a promising strategy for regulating glucose homeostasis.
- Further research into orphan GPCRs may unlock novel treatment avenues for diabetes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
G-protein Coupled Receptors
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Types of Receptors: Internal Receptors
Similar to membrane-bound receptors, the binding of a ligand to the intracellular receptor of causes a conformational change in the...

